Monday, April 4, 2011

Follow up on All Things Makena

BioCentury TV covers the wild week that was KV Pharmaceutical's, after the FDA nixed their plans for exclusive marketing of a form of progesterone that had previously been used widely and cheaply for decades by women to prevent premature birth.  See the video report here and read the PDF followup here.

No comments: